Cart
sales@molnova.com
Home - Products - Metabolic Enzyme/Protease - Casein Kinase - Casein kinase 1δ-IN-3

Casein kinase 1δ-IN-3

CAS No. 349438-77-3

Casein kinase 1δ-IN-3( —— )

Catalog No. M35796 CAS No. 349438-77-3

Casein kinase 1δ-IN-3 (Compound 23a) is an inhibitor of casein kinase 1 delta (CK1δ) with a pIC50 of 6.5376 M.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 64 In Stock
10MG 111 In Stock
25MG 227 In Stock
50MG 361 In Stock
100MG 530 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Casein kinase 1δ-IN-3
  • Note
    Research use only, not for human use.
  • Brief Description
    Casein kinase 1δ-IN-3 (Compound 23a) is an inhibitor of casein kinase 1 delta (CK1δ) with a pIC50 of 6.5376 M.
  • Description
    Casein kinase 1δ-IN-3 (Compound 23a) is a casein kinase 1 delta (CK1d) inhibitor with a pIC50 of 6.5376 M.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Casein Kinase
  • Recptor
    Casein Kinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    349438-77-3
  • Formula Weight
    312.39
  • Molecular Formula
    C17H16N2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 62.5 mg/mL (200.07 mM; Ultrasonic )
  • SMILES
    COc1ccccc1CC(=O)Nc1nc2ccc(C)cc2s1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Makhuri FR, et al. Computer-aided scaffold hopping to identify a novel series of casein kinase 1 delta (CK1d) inhibitors for amyotrophic lateral sclerosis. Eur J Pharm Sci. 2015 Oct 12;78:151-62.?
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Longdaysin

    Longdaysin is an inhibitor of CK1α and CK1δ (IC50s: 5.6/8.8 μM). It also can inhibit ERK2 (IC50: 52 μM).

  • CK2α-IN-1

    CK2α-IN-1 is a selective non-ATP-competitive CK2α inhibitor with an IC50 of 7.0 μM and a Ki of 1.6 μM.CK2α-IN-1 exhibits potential anticancer activity and can be used in cancer research.

  • BTX161

    BTX161 is a thalidomide analog that mediates degradation of CKIα better than lenalidomide in human AML cells and activates DDR and p53.

Sign In Join Free